News Article

A Proteomics Perspective on Precision Medicine

Dear Colleagues!
Please join us on July 18 in München/Neuherberg for a cost-free kick-off symposium, "A Proteomics Perspective on Precision Medicine". 

Learn how protein biomarker discovery, amongst other approaches, has contributed to progress in a variety of different clinical research areas such as general health, systems medicine, cardiovascular disease, dermatology, metabolic and inflammatory diseases. This varied selection of interesting presentations should give you ideas on how you could use protein biomarkers in your research to drive precision medicine to the next level.

The symposium is a joint effort between the Helmholtz Center, where there has been an Olink platform operational since end of 2018, and Olink Proteomics.
With the installation of the platform, the Research Unit Protein Science and Core Facility Proteomics are certified to perform Olink biomarker studies and assays.

Date:     Wednesday, 18.7.2019   12:45 – 18:00
Venue:  Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764 Neuherberg
             HDC Building 3620, Seminar room 041






Opening Session
Stefanie Hauck, Proteomics Core Facility, Helmholtz Zentrum München, Germany



Introduction to PEA Technology
Karsten Strauß, Olink Proteomics, Sweden



Challenges and Opportunities in Study Planning and Data Interpretation
Marianne Sandin, Olink Proteomics, Sweden



Longitudinal Wellness Profiling
Fredrik Edfors, Systems Biology, KTH, Sweden



Complementarity of Olink and Mass Spectrometry-based Proteomics
Stefanie Hauck, Research Unit Protein Science and Core Facility Proteomics, Helmholtz Zentrum München, Germany



Proteomics in Dermatology
Patrick M. Brunner, Department of Dermatology, Medical University of Vienna, Austria



Coffee Break & Networking



Cross-platform comparison of genetic associations across the human plasma proteome
Claudia Langenberg, MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, United Kingdom



Protein Biomarkers and Risk of Cardio-Metabolic Diseases
Barbara Thorand, Diabetes Epidemiology, Helmholtz Zentrum München, Germany



Potential Role of Proteomics in Cardiovascular Risk Assessment
Wolfgang Koenig, German Heart Centre Munich, Germany



Biomarker Measurements in Patients - Implications for Mechanistic Understanding and Diagnostic Decision-Making
Anne Hilgendorff, Comprehensive Pneumology Center, Helmholtz Zentrum München, Germany



Closing Remarks
Stefanie Hauck


We hope to welcome you on July 18!
With best regards

Stefanie Hauck                                            Karsten Strauß
HMGU                                                          Olink Proteomics
Neuherberg                                                 Uppsala, Sweden


Please register for this free event, to allow us for planning seat numbers and coffee break. Please send an email to:

Directions to Helmholtz Zentrum München

Location HDC Building